Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.45M Buy
9,969
+3,911
+65% +$540K 0.76% 23
2026
Q2
$778K Buy
6,058
+5,521
+1,028% +$646K 0.07% 28
2026
Q1
$64.6K Hold
537
– – 0.39% 35
2025
Q4
$56.5K Buy
+537
New +$50.4K ﹤0.01% 39

Other funds holding MRK

Swiss Re's MRK Position: Q3 2026 in Review

Swiss Re increased its Merck (MRK) stake by 65% in Q3 2026, buying an estimated $540K and bringing the position to 9,969 shares worth $1.45M. The position accounts for 0.76% of the portfolio, ranked #23.

Swiss Re first reported a position in MRK in Q4 2025 and has held it in 4 quarters since. 3,974 funds tracked by Wall St. Rank hold MRK as of Q3 2026.

  • Swiss Re held 9,969 shares of Merck worth $1.45M as of Q3 2026.
  • Swiss Re bought 3,911 Merck shares in Q3 2026, an estimated $540K.
  • Merck made up 0.76% of Swiss Re's portfolio in Q3 2026, its #23 holding.
  • Swiss Re first reported a position in Merck in Q4 2025 and has held it in 4 quarters since.
  • 3,974 funds tracked by Wall St. Rank held Merck as of Q3 2026.

Based on Swiss Re's 13F filing for Q3 2026, filed 6 Nov 2026.